A:\_12B_25.DOC
UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION OMB
Washington, D.C. 20549 Num
FORM 12b-25 ber
: 3235-0058
Exp
ire
s: May 31, 1997
Est
ima
ted
ave
rag
e
bur
den
hou
rs
per
res
pon
se 2.50
NOTIFICATION OF LATE FILING SEC FILE NU
MBER
001-
13460
(Check CUSIP NUMBER
One): o Form 10-K o 190495 10 1
Form 20-F o Form 11-K x Form 10-Q o
Form N-SAR
For Period Ended: MARCH 31, 2000
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Read Instruction (on back page) Before Preparing Form. Please Print or T
ype.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
N/A
PART I - REGISTRANT INFORMATION
PHYAMERICA Physician Group, Inc.
Full Name of Registrant
COASTAL PHYSICIAN GROUP, INC.
Former Name if Applicable
2828 Croasdaile Drive
Address of Principal Executive Office (Street and Number)
Durham, North Carolina 27705
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
(a The reasons described in reasonable detail in Part III of this
) form could not be eliminated without unreasonable effort or
expense;
x (b The subject annual report, semi-annual report, transition report
) on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof,
will be filed on or before the fifteenth calendar day following
the prescribed due date; or the subject quarterly report or
transition report on Form 10-Q, or portion thereof will be filed
on or before the fifth calendar day following the prescribed due
date; and
(c The accountant's statement or other exhibit required by Rule 12b-
) 25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K,
10-Q, N-SAR, or the transition report or portion thereof, could not be
filed within the prescribed time period. (Attach Extra Sheets if Needed)
The registrant had to reorganize responsibilities due to the resigination
of W. Randall Dickerson from his positions as Executive Vice President,
Chief Financial Officer and Chief Accounting Officer. Mr. Dickerson also
resigned from the Board of Directors. These resignations were effective
April 30, 2000. Due to the time and effort devoted to reorganizing
responsibilities, the registrant is unable to file its quarterly report on
Form 10-Q for the quarter ended March 31, 2000 within the prescribed time
period.
SEC 1344 (6/94)
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
STEVEN M. SCOTT, M.D.
Chairman of the Board of Directors, President
and Chief Executive Officer (919) 383-0355
(Name) (Area Code)
(Telephone Number)
(2)Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period
that the registrant was required to file such report(s) been filed?
If answer is no, identify
reports(s).xYes oNo
(3)Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or portion
thereof? xYes oNo
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
THERE WILL BE A SIGNIFICANT CHANGE IN TEH RESULTS OF OPERATIONS FROM
THE CORRESPONDING PERIOD FOR THE LAST YEAR DUE TO THE ACQUISITION OF
STERLING HEALTHCARE GROUP ON JULY 8, 1999. WE ARE UNABLE TO QUANTIFY
THE AMOUNT OF CHANGE AT THIS TIME.
PhyAmerica Physician Group, Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date MAY 15, 2000 By /s/ Steven M. Scott, M.D.
Steven M. Scott, M.D.
Chairman of the Board of Directors,
President and
Chief Executive Officer
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and
title of the person signing the form shall be typed or printed beneath the
signature. If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer), evidence of
the representative's authority to sign on behalf of the registrant shall
be filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).
GENERAL INSTRUCTIONS
1.This form is required by Rule 12b-25(17 CFR 240.12b-25) of the General
Rules and Regulations under the Securities Exchange Act of 1934.
2.One signed original and four conformed copies of this form and
amendments thereto must be completed and filed with the Securities and
Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3
of the General Rules and Regulations under the Act. The information
contained in or filed with the form will be made a matter of public
record in the Commission files.
3.A manually signed copy of the form and amendments thereto shall be filed
with each national securities exchange on which any class of securities
of the registrant is registered.
4.Amendments to the notifications must also be filed on form 12b-25 but
need not restate information that has been correctly furnished. The
form shall be clearly identified as an amended notification.
5.Electronic Filers. This form shall not be used by electronic filers
unable to timely file a report solely due to electronic difficulties.
Filers unable to submit a report within the time period prescribed due
to difficulties in electronic filing should comply with either Rule 201
or Rule 202 of Regulation S-T (232.201 or 232.202 of this chapter) or
apply for an adjustment in filing date pursuant to Rule 13(b) of
Regulation S-T (232.13(b) of this chapter).
